BlackRock Fund Advisors’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$341M Buy
2,376,204
+102,788
+5% +$13.1M 0.06% 332
2016
Q3
$268M Buy
2,273,416
+55,447
+2% +$6.66M 0.06% 400
2016
Q2
$235M Buy
2,217,969
+59,026
+3% +$6.58M 0.05% 418
2016
Q1
$241M Buy
2,158,943
+35,288
+2% +$4.47M 0.06% 392
2015
Q4
$333M Sell
2,123,655
-48,341
-2% -$7.04M 0.08% 259
2015
Q3
$285M Buy
2,171,996
+48,864
+2% +$7.84M 0.07% 274
2015
Q2
$369M Buy
2,123,132
+105,561
+5% +$19M 0.09% 214
2015
Q1
$348M Buy
2,017,571
+45,778
+2% +$6.98M 0.08% 236
2014
Q4
$255M Sell
1,971,793
-33,280
-2% -$4.29M 0.06% 334
2014
Q3
$258M Buy
2,005,073
+82,884
+4% +$8.54M 0.07% 285
2014
Q2
$170M Sell
1,922,189
-61,334
-3% -$5.9M 0.05% 489
2014
Q1
$187M Sell
1,983,523
-5,995
-0.3% -$613K 0.06% 411
2013
Q4
$225M Buy
1,989,518
+141,028
+8% +$12.7M 0.07% 317
2013
Q3
$146M Buy
1,848,490
+145,102
+9% +$10.6M 0.05% 483
2013
Q2
$112M Buy
+1,703,388
New +$110M 0.04% 585

Other funds holding UTHR